Fennec Pharmaceuticals (FENC) Exchange Rate Effect (2011)
Fennec Pharmaceuticals' (FENC) quarterly Exchange Rate Effect came in at -$110000.0 in Q4 2011, down 478.95% on a QoQ basis from -$19000.0 in Q3 2011.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Exchange Rate Effect (2011) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 1 years of Exchange Rate Effect data on file, last reported at -$110000.0 in Q4 2011.
- Quarterly Exchange Rate Effect changed N/A year-over-year to -$110000.0 in Q4 2011, while the trailing twelve-month figure through Sep 2012 was -$110000.0 (changed N/A YoY) and the FY2011 annual result came in at $10000.0, changed N/A from the prior year.
- Exchange Rate Effect slipped to -$110000.0 in Q4 2011, from -$19000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $124000.0 in Q1 2011 to a low of -$110000.0 in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | -110,000.00 |
| Sep 30, 2011 | -19,000.00 |
| Jun 30, 2011 | 15,000.00 |
| Mar 31, 2011 | 124,000.00 |